Medicare Enrolled
Dr. Mobeen Choudhri, MD
Interventional Pain Medicine Physician · Bellaire, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Choudhri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Choudhri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Choudhri
Dr. Mobeen Choudhri is an interventional pain medicine physician in Bellaire, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Choudhri performed 4,007 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Choudhri received a total of $66,384 from 72 pharmaceutical and/or device companies across 1591 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Choudhri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 24% volume in TX
$66,384 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,007
Medicare services
Top 24% in TX for interventional pain medicine physician
Not available
Unique patients (not deduplicated)
$120
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
857 | $61 | $287 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
520 | $194 | $795 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
444 | $92 | $434 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
363 | $1 | $56 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
141 | $142 | $896 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
132 | $240 | $988 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
123 | $152 | $626 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
122 | $88 | $417 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
115 | $63 | $295 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
109 | $53 | $296 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
107 | $0 | $5 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
97 | $188 | $1,358 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
96 | $100 | $684 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
91 | $394 | $3,226 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
87 | $216 | $1,326 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
78 | $195 | $1,097 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
66 | $88 | $438 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $116 | $669 |
| Injection, methylprednisolone acetate, 40 mg | 61 | $6 | $9 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
58 | $177 | $1,037 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
52 | $103 | $684 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
51 | $198 | $1,372 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
35 | $194 | $967 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
31 | $472 | $3,136 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
30 | $698 | $3,050 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
29 | $285 | $1,426 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
24 | $74 | $391 |
| Knee nerve block injection with imaging guidance An injection of anesthetic and/or steroid medication into a nerve branch of the knee, performed using imaging guidance to ensure accurate placement. |
13 | $177 | $958 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
11 | $148 | $967 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$66,384
Total received (2018-2024)
Avg $9,483/year across 7 years
Top 4% in TX for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
1,591
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,537
2023
$9,347
2022
$6,047
2021
$8,586
2020
$6,862
2019
$14,815
2018
$12,188
Payments by company (2024)
Medtronic, Inc.
$4,601
SI-BONE, INC.
$1,564
Boston Scientific Corporation
$1,011
Vertos Medical, Inc.
$283
ABBVIE INC.
$216
PFIZER INC.
$174
Saluda Medical Americas, Inc.
$153
Bioventus LLC
$150
Nalu Medical, Inc.
$119
Nevro Corp.
$98
Averitas Pharma Inc.
$48
Abbott Laboratories
$30
Collegium Pharmaceutical, Inc.
$24
Merz Pharmaceuticals, LLC
$20
PAINTEQ LLC
$19
Stryker Corporation
$19
BIOCOMPOSITES INC
$10
Top 3 companies account for 84.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$15,905
Abbott Laboratories
$6,397
Medtronic USA, Inc.
$5,741
Boston Scientific Corporation
$5,224
SI-BONE, Inc.
$4,026
SI-BONE, INC.
$3,046
BOSTON SCIENTIFIC CORPORATION
$2,899
Nuvectra Corporation
$2,591
Nevro Corp.
$2,159
Saluda Medical Americas, Inc.
$2,083
PFIZER INC.
$1,825
Medtronic Vascular, Inc.
$1,629
Relievant Medsystems, Inc.
$1,228
Vertos Medical, Inc.
$987
Teva Pharmaceuticals USA, Inc.
$968
Amgen Inc.
$743
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$628
Collegium Pharmaceutical, Inc.
$623
AbbVie Inc.
$582
Pacira Pharmaceuticals Incorporated
$510
ABBVIE INC.
$480
Daiichi Sankyo Inc.
$463
Allergan Inc.
$389
Lilly USA, LLC
$373
Horizon Therapeutics plc
$284
Eisai Inc.
$276
Novartis Pharmaceuticals Corporation
$263
Allergan, Inc.
$250
ARBOR PHARMACEUTICALS, INC.
$235
SCILEX PHARMACEUTICALS INC.
$232
Bioventus LLC
$201
BioDelivery Sciences International, Inc.
$188
Scilex Pharmaceuticals Inc.
$174
Takeda Pharmaceuticals U.S.A., Inc.
$160
Merz North America, Inc.
$160
Merz Pharmaceuticals, LLC
$158
Zynex Medical, Inc.
$155
Stryker Corporation
$139
Lundbeck LLC
$125
Biohaven Pharmaceutical Holding Company Ltd.
$119
Nalu Medical, Inc.
$119
Egalet US Inc
$118
Electronic Waveform Lab, Inc.
$104
Globus Medical, Inc.
$103
MERZ NORTH AMERICA, INC.
$102
TerSera Therapeutics LLC
$98
PAINTEQ LLC
$96
FUJIFILM SonoSite, Inc.
$95
Flexion Therapeutics, Inc.
$92
Averitas Pharma Inc.
$87
IDORSIA PHARMACEUTICALS US INC
$65
Pernix Therapeutics Holdings, Inc.
$61
Supernus Pharmaceuticals, Inc.
$61
US WorldMeds, LLC
$59
AstraZeneca Pharmaceuticals LP
$53
Arbor Pharmaceuticals, Inc.
$49
EISAI INC.
$46
Sentynl Therapeutics, Inc.
$40
ASSERTIO THERAPEUTICS, Inc.
$38
Shionogi Inc
$36
Zyla Life Sciences
$35
Tactile Systems Technology Inc
$30
IMPEL PHARMACEUTICALS INC.
$30
Bausch Health US, LLC
$29
Avanos Medical
$26
GRT US Holding, Inc.
$24
Zyla Life Sciences, Inc.
$17
Kaleo, Inc.
$13
Horizon Pharma plc
$12
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$11
Vertiflex, Inc.
$11
BIOCOMPOSITES INC
$10
Top 3 companies account for 42.2% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AIMOVIG · AJOVY · ARYMO ER · AUTOFILL · AXIUM · Accurian · Aimovig · Algovita · Amitiza · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · COLOGUARD · COMIRNATY · COOLIEF COOLED RADIOFREQUENCY · CREO · ClosureFast · DUEXIS · Dayvigo · Durolane · EMBEDA · EMGALITY · ETERNA · EUCRISA · Evoke · Evoke SCS · Evzio · Exparel · FIXATE · Flexitouch Plus · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · Gralise · Horizant · IFUSE IMPLANT · IFUSE IMPLANT SYSTEM · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - MULTIGEN 2RF · Intracept · Iovera System · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LUCEMYRA · LYRICA · Levorphanol · Lucemyra · Lucemyra/Lofexidine · MIDAS REX · MIGRANAL · MILD DEVICE KIT · MOVANTIK · Morphabond ER · NURTEC ODT · Nalu Neurostimulation System · Nexwave · OCTRODE · OSTEOCOOL RF ABLATION SYSTEM · Omnia · PAINTEQ · PENNSAID · PRIALT · PROCLAIM · PRODIGY · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · S Series Ultrasound System · SCS IPGs · SPECTRA WAVEWRITER · SPRIX · STIMROUTER IMPLANTABLE KIT · STIMULAN · SUPERION · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · TROKENDI XR · Trudhesa · UBRELVY · V-LOC 180 · VANTA ADAPTIVESTIM · VECTRIS · VYEPTI · Vanta · VenaSeal · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XEOMIN · XTAMPZA · XTAMPZAER · Xeomin · Xtampza ER · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · iFuse Implant · mild Device Kit
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Interventional pain medicine physicians in nearby ZIP areas
28
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
BEHAVIORAL HOSPITAL OF BELLAIRE
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Choudhri is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Choudhri experienced with drug screening test?
Based on Medicare claims data, Dr. Choudhri performed 857 drug screening test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Choudhri receive payments from pharmaceutical companies?
Yes. Dr. Choudhri received a total of $66,384 from 72 companies across 1,591 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Choudhri's costs compare to other interventional pain medicine physicians in Bellaire?
Dr. Choudhri's average Medicare payment per service is $120. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Choudhri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Bellaire
Browse interventional pain medicine physicians in Bellaire ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in TX
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in TX
Which TX interventional pain medicine physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology